Skip to main content

IE 11 is not supported. For an optimal experience visit our site on another browser.

June 20, 202401:39

  • FAA says Southwest plane flew unusually low over Oklahoma City suburb

    01:05

  • State of the economy aboard a working schooner

    02:43

  • Presidential campaigns battle over videos the Biden team dubs “cheap fakes”

    03:01

  • Suspect wanted in multiple murders captured in Arkansas

    01:26

  • Acclaimed actor Donald Sutherland dies at 88

    01:39

  • Now Playing

    WHO issues warning about fake weight-loss drugs

    01:39

  • UP NEXT

    Beluga whales evacuated from Ukraine in complex mission

    01:29

  • Power issues disrupt train service in New York area

    00:55

  • Widespread flooding in South Texas after Alberto makes landfall

    02:05

  • Senate bill aims to crack down on deepfake porn images

    01:57

  • Suspect in teen’s rape arrested with neighbors’ help, police say

    01:30

  • Jails across America replace in-person visits with expensive video calls

    04:08

  • Putin and Kim Jong Un sign strategic partnership, deepening ties

    01:36

  • Honor Flight Network flies 26 Black veterans to Washington for Juneteenth

    01:33

  • Tropical Storm Alberto lashes Texas as heat wave persists

    01:56

  • Netanyahu accuses U.S. of withholding military aid for Israel

    02:00

  • Justin Timberlake arrested on DWI charge on Long Island

    01:38

  • Maine now a hot spot for marijuana growing by Chinese criminal groups, officials say

    04:00

  • Biden moves to protect undocumented spouses of citizens from deportation

    01:55

  • Arms race to supply warring sides in Russia-Ukraine conflict

    01:32

The World Health Organization issued an alert on falsified versions of Ozempic, the popular drug used to treat type 2 diabetes and obesity. The WHO warned health care professionals and the public to be aware of the counterfeits, which it said are increasing as demand for the drugs grows. NBC News’ Anne Thompson reports.

Source

Leave a Reply